Ability to predict C-diff mortality nearly doubled with new guidelines

December 09, 2020

Clostridioides difficile infection (CDI) is the most common health care-associated infection in the United States, causing an estimated 12,800 deaths each year. The deadly and notoriously stubborn superbug, C. diff has been hard to spot and harder to stop. In 2017, two organizations leading the war on C. diff updated their guidelines for assessing patients and the severity of their infections. Now a University of Houston team, led by Kevin Garey, professor of pharmacy practice and chair of the UH College of Pharmacy Department of Pharmacy Practice and Translational Research, has proven that specific updates were well advised. Garey is reporting his findings in the journal Open Forum Infectious Diseases.

"Whenever changes to national guidelines are based on expert opinion only, that is an opportunity to do a research project to see if those experts were correct," said Garey, who was, in fact, one of the experts at the table. Such was the case for the 2017 guidelines from The Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) whose guidelines for C. diff treatment and diagnosis are widely considered one of the most influential on the planet, according to Garey.

The change in the guidelines revolved around how to assess damage to the kidney caused by the fluid loss associated with severe CDI. Kidney damage can be detected when blood levels show increased creatinine, a waste product formed when creatine in muscles breaks down. A normal range for serum creatinine (SCr) level is generally below one milligram per deciliter of blood (1mg/dL).

"There are several ways to use creatinine to determine if someone has kidney damage. A common method is to use at least a 50% increase in creatinine from a previous measurement, but in many cases this prior measurement doesn't exist," said Garey.

For the new guidelines, IDSA and SHEA recognized this problem and chose another method to determine kidney damage; namely simply using a creatinine value above 1.5 mg/dL at the time of infection to indicate kidney damage. However, this change was based on expert opinion and had not been tested scientifically.

Garey and his team of UH pharmacy students, postdocs, research scientists and faculty set out to prove the criteria was valid, and they found remarkable success in the new severity classification.

"Using the new single creatinine measurement above 1.5 to define CDI severity was fourfold more predictive in identifying patients likely to die during their hospitalization," said Garey. "When combined with increased white blood cell count, another severity predictor, the newly revised severity predictor was twofold better at predicting mortality."

The newly revised severity assessment allows doctors to understand when they have a severely ill patient at high risk for mortality and tailor treatment accordingly.

Garey and team studied 705 adult patients hospitalized with CDI in several hospitals around Houston.

"The revised SCr criterion was independently associated with increased odds of mortality when analyzed as a single criterion and combined with WBC as per the IDSA-SHEA severity guidelines," reports Garey.

Equally great, said Garey, is that UH students did much of the work. "This is a wonderful demonstration that professional pharmacy students can learn science and at the same time provide meaningful science to the world. You can sleep easier at night knowing UH is looking through the fine details of guidelines and making sure recommendations are correct," said Garey.
-end-
UH College of Pharmacy students working on the project included Kimberly Nebo, Hannah Y. Chan, Ngoc-Linh T. Tran, and Sheena Antony. Travis J. Carlson, now faculty at High Point University, was lead author and a postdoctoral fellow in Garey's lab at the time of the study.

University of Houston

Related Mortality Articles from Brightsurf:

Being in treatment with statins reduces COVID-19 mortality by 22% to 25%
A research by the Universitat Rovira i Virgili (URV) and Pere Virgili Institut (IISPV) led by LluĂ­s Masana has found that people who are being treated with statins have a 22% to 25% lower risk of dying from COVID-19.

Mortality rate higher for US rural residents
A recent study by Syracuse University sociology professor Shannon Monnat shows that mortality rates are higher for U.S. working-age residents who live in rural areas instead of metro areas, and the gap is getting wider.

COVID-19, excess all-cause mortality in US, 18 comparison countries
COVID-19 deaths and excess all-cause mortality in the U.S. are compared with 18 countries with diverse COVID-19 responses in this study.

New analysis shows hydroxychloroquine does not lower mortality in COVID-19 patients, and is associated with increased mortality when combined with the antibiotic azithromycin
A new meta-analysis of published studies into the drug hydroxychloroquine shows that it does not lower mortality in COVID-19 patients, and using it combined with the antibiotic azithromycin is associated with a 27% increased mortality.

Hydroxychloroquine reduces in-hospital COVID-19 mortality
An Italian observational study contributes to the ongoing debate regarding the use of hydroxychloroquine in the current pandemic.

What's the best way to estimate and track COVID-19 mortality?
When used correctly, the symptomatic case fatality ratio (sCFR) and the infection fatality ratio (IFR) are better measures by which to monitor COVID-19 epidemics than the commonly reported case fatality ratio (CFR), according to a new study published this week in PLOS Medicine by Anthony Hauser of the University of Bern, Switzerland, and colleagues.

COVID-19: Bacteriophage could decrease mortality
Bacteriophage can reduce bacterial growth in the lungs, limiting fluid build-up.

COPD and smoking associated with higher COVID-19 mortality
Current smokers and people with chronic obstructive pulmonary disease (COPD) have an increased risk of severe complications and higher mortality with COVID-19 infection, according to a new study published May 11, 2020 in the open-access journal PLOS ONE by Jaber Alqahtani of University College London, UK, and colleagues.

Highest mortality risks for poor and unemployed
Large dataset shows that income, work status and education have a clear influence on mortality in Germany.

Addressing causes of mortality in Zambia
Despite the fact that people in sub-Saharan Africa are now living longer than they did two decades ago, their average life expectancy remains below that of the rest of the world population.

Read More: Mortality News and Mortality Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.